Wallace Laboratories have recently introduced a number of preparations in Britain which have for some time been available in the U. S. (see MIMS, January, 1964). Mebutamate (Capla - Wallace) is one of these. It is closely related to meprobamate, and is intended for the treatment of mild hypertension. It has not however been shown that the use of any hypotensive drug improves the prognosis in mild hypertension.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.